These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 38689296)
1. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer. Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296 [TBL] [Abstract][Full Text] [Related]
3. Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer. Xu F; Yu S; Han J; Zong M; Tan Q; Zeng X; Fan L Clin Transl Gastroenterol; 2021 Aug; 12(8):e00386. PubMed ID: 34382948 [TBL] [Abstract][Full Text] [Related]
4. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study. Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049 [TBL] [Abstract][Full Text] [Related]
6. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review. Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754 [TBL] [Abstract][Full Text] [Related]
7. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study. Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456 [TBL] [Abstract][Full Text] [Related]
8. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population. Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022 [TBL] [Abstract][Full Text] [Related]
9. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215 [TBL] [Abstract][Full Text] [Related]
10. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study. Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158 [TBL] [Abstract][Full Text] [Related]
11. SEPT9: A Specific Circulating Biomarker for Colorectal Cancer. Song L; Li Y Adv Clin Chem; 2015; 72():171-204. PubMed ID: 26471083 [TBL] [Abstract][Full Text] [Related]
12. Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study. Liu Y; Tham CK; Ong SY; Ho KS; Lim JF; Chew MH; Lim CK; Zhao Y; Tang CL; Eu KW Biomarkers; 2013 Aug; 18(5):399-405. PubMed ID: 23862763 [TBL] [Abstract][Full Text] [Related]
13. The role of Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406 [TBL] [Abstract][Full Text] [Related]
14. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer. Luo H; Zhao Q; Wei W; Zheng L; Yi S; Li G; Wang W; Sheng H; Pu H; Mo H; Zuo Z; Liu Z; Li C; Xie C; Zeng Z; Li W; Hao X; Liu Y; Cao S; Liu W; Gibson S; Zhang K; Xu G; Xu RH Sci Transl Med; 2020 Jan; 12(524):. PubMed ID: 31894106 [TBL] [Abstract][Full Text] [Related]
15. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer. Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker. Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373 [TBL] [Abstract][Full Text] [Related]
17. High methylation of the SEPT9 gene in Chinese colorectal cancer patients. Su XL; Wang YF; Li SJ; Zhang F; Cui HW Genet Mol Res; 2014 Jan; 13(2):2513-20. PubMed ID: 24535900 [TBL] [Abstract][Full Text] [Related]
18. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection. Symonds EL; Pedersen SK; Murray DH; Jedi M; Byrne SE; Rabbitt P; Baker RT; Bastin D; Young GP Clin Epigenetics; 2018; 10():63. PubMed ID: 29796114 [TBL] [Abstract][Full Text] [Related]
19. The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis. Song L; Jia J; Peng X; Xiao W; Li Y Sci Rep; 2017 Jun; 7(1):3032. PubMed ID: 28596563 [TBL] [Abstract][Full Text] [Related]
20. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer. Tham C; Chew M; Soong R; Lim J; Ang M; Tang C; Zhao Y; Ong SY; Liu Y Cancer; 2014 Oct; 120(20):3131-41. PubMed ID: 24925595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]